1. 1) Setchell KD, Clerici C. Equol: history, chemistry, and formation. J. Nutr., 140, 1355S–1362S (2010).
2. 2) Setchell KD, Clerici C. Equol: pharmacokinetics and biological actions. J. Nutr., 140, 1363S–1368S (2010).
3. 3) Rafii F. The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol. Metabolites, 5, 56–73 (2015).
4. 4) Jackman KA, Woodman OL, Sobey CG. Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights. Curr. Med. Chem., 14, 2824–2830 (2007).
5. 5) Ahuja V, Miura K, Vishnu A, Fujiyoshi A, Evans R, Zaid M, Miyagawa N, Hisamatsu T, Kadota A, Okamura T, Ueshima H, Sekikawa A. Significant inverse association of equol-producer satus with coronary artery calcification but not dietary isoflavones in healthy Japanese men. Br. J. Nutr., 117, 260–266 (2017).